Analysis and Commentary 7/10/20 Analysis and Commentary 7/10/20 CBER Director on COVID-19 and Vaccine Development Read More Advocacy at a Glance 7/10/20 Advocacy at a Glance 7/10/20 Advocacy at a Glance Read More Analysis and Commentary 6/26/20 Analysis and Commentary 6/26/20 FDA Is Its People … and They Need Our Support (Redux) Read More Advocacy at a Glance 6/26/20 Advocacy at a Glance 6/26/20 Advocacy at a Glance Read More Analysis and Commentary 6/19/20 Analysis and Commentary 6/19/20 How Well Is This Year's Appropriation Process Working? Read More Advocacy at a Glance 6/19/20 Advocacy at a Glance 6/19/20 Advocacy at a Glance Read More Analysis and Commentary 6/12/20 Analysis and Commentary 6/12/20 "I Believe in FDA Exceptionalism and You Should Too" Read More Advocacy at a Glance 6/12/20 Advocacy at a Glance 6/12/20 Advocacy at a Glance Read More Analysis and Commentary 6/5/20 Analysis and Commentary 6/5/20 Pandemic Actions Taken ... and Lessons Learned Read More Advocacy at a Glance 6/5/20 Advocacy at a Glance 6/5/20 Advocacy at a Glance Read More Advocacy at a Glance 5/22/20 Advocacy at a Glance 5/22/20 Hurry Up and Slow Down (Once Again) Read More Advocacy at a Glance 5/22/20 Advocacy at a Glance 5/22/20 Advocacy at Glance Read More Analysis and Commentary 5/15/20 Analysis and Commentary 5/15/20 How H.R. 6800 Might Impact the FDA Read More Advocacy at a Glance 5/15/20 Advocacy at a Glance 5/15/20 Advocacy at a Glance Read More Analysis and Commentary 5/8/20 Analysis and Commentary 5/8/20 The Frieden Health Defense Funding Proposition Read More Advocacy at a Glance 5/8/20 Advocacy at a Glance 5/8/20 Advocacy at a Glance Read More Analysis and Commentary 5/1/20 Analysis and Commentary 5/1/20 No Need for a Crystal Ball in Some Scenarios Read More Advocacy at a Glance 5/1/20 Advocacy at a Glance 5/1/20 Advocacy at a Glance Read More Analysis and Commentary 4/24/20 Analysis and Commentary 4/24/20 How Can Congress Agree to Appropriations for FY 21? Read More Advocacy at a Glance 4/24/20 Advocacy at a Glance 4/24/20 Advocacy at a Glance Read More Newer Posts Older Posts
Analysis and Commentary 7/10/20 Analysis and Commentary 7/10/20 CBER Director on COVID-19 and Vaccine Development Read More
Analysis and Commentary 6/26/20 Analysis and Commentary 6/26/20 FDA Is Its People … and They Need Our Support (Redux) Read More
Analysis and Commentary 6/19/20 Analysis and Commentary 6/19/20 How Well Is This Year's Appropriation Process Working? Read More
Analysis and Commentary 6/12/20 Analysis and Commentary 6/12/20 "I Believe in FDA Exceptionalism and You Should Too" Read More
Analysis and Commentary 6/5/20 Analysis and Commentary 6/5/20 Pandemic Actions Taken ... and Lessons Learned Read More
Advocacy at a Glance 5/22/20 Advocacy at a Glance 5/22/20 Hurry Up and Slow Down (Once Again) Read More
Analysis and Commentary 5/15/20 Analysis and Commentary 5/15/20 How H.R. 6800 Might Impact the FDA Read More
Analysis and Commentary 5/8/20 Analysis and Commentary 5/8/20 The Frieden Health Defense Funding Proposition Read More
Analysis and Commentary 5/1/20 Analysis and Commentary 5/1/20 No Need for a Crystal Ball in Some Scenarios Read More
Analysis and Commentary 4/24/20 Analysis and Commentary 4/24/20 How Can Congress Agree to Appropriations for FY 21? Read More
